Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Affibody and Nuclisome join forces to develop cancer therapeutics

Dec. 23, 2011

GlaxoSmithKline presents novel protein kinase inhibitors

Dec. 23, 2011

Merck & Co. discloses new B-raf inhibitors

Dec. 23, 2011

VANTAGE 88 reveals activity of combination therapy for multiple myeloma

Dec. 23, 2011

Hande Starlake Bioscience prepares new PARP inhibitors

Dec. 22, 2011

Novel epidermal growth factor receptor inhibitors synthesized by Chinese university

Dec. 22, 2011

NewGen Therapeutics acquires targeted oncology programs

Dec. 22, 2011

Hanmi and Kinex sign Orascovery licensing agreement

Dec. 22, 2011

Roche's Zelboraf receives CHMP opinion

Dec. 21, 2011

Scientists at AstraZeneca present new therapy for AML

Dec. 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...